Published in Mol Cell Biol on June 01, 1999
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell (2006) 11.79
Systematic discovery of in vivo phosphorylation networks. Cell (2007) 6.94
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol (2007) 4.19
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev (2003) 3.67
Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. Genes Dev (2004) 2.69
Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol (2005) 2.66
Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat Genet (2008) 2.42
Proteomic analysis of interchromatin granule clusters. Mol Biol Cell (2004) 2.12
Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell (2013) 2.06
Barrier-to-autointegration factor: major roles in chromatin decondensation and nuclear assembly. J Cell Biol (2002) 1.88
Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment. RNA (2006) 1.83
The inner nuclear envelope as a transcription factor resting place. EMBO Rep (2007) 1.61
Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog (2012) 1.53
Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol (2009) 1.41
Regulation of cyclin D1 RNA stability by SNIP1. Cancer Res (2008) 1.33
A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog (2005) 1.30
Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway. J Proteome Res (2006) 1.23
A genome-wide survey of RS domain proteins. RNA (2001) 1.15
Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome Sci (2010) 1.14
The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation. J Biol Chem (2011) 1.11
PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci U S A (2011) 1.11
Gps2, a protein partner for human papillomavirus E6 proteins. J Virol (2001) 1.09
Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity. Neuropsychopharmacology (2007) 1.09
FF domains of CA150 bind transcription and splicing factors through multiple weak interactions. Mol Cell Biol (2004) 1.09
Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Mol Cell Biol (2007) 1.08
Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays. J Proteome Res (2008) 1.06
Bcl-2 modulation to activate apoptosis in prostate cancer. Mol Cancer Res (2009) 1.01
BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A (2012) 1.01
The nuclear envelope LEM-domain protein emerin. Nucleus (2013) 0.99
Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells. J Proteome Res (2011) 0.98
Conditionally replicating adenoviruses for cancer treatment. Curr Cancer Drug Targets (2007) 0.98
Functions of Kaposi's sarcoma-associated herpesvirus microRNAs. Biochim Biophys Acta (2011) 0.95
MiR-7 triggers cell cycle arrest at the G1/S transition by targeting multiple genes including Skp2 and Psme3. PLoS One (2013) 0.94
BCLAF1 is a radiation-induced H2AX-interacting partner involved in γH2AX-mediated regulation of apoptosis and DNA repair. Cell Death Dis (2012) 0.89
The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication. Wiley Interdiscip Rev Syst Biol Med (2010) 0.88
Human telomerase reverse transcriptase promoter-driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions. Hum Gene Ther (2008) 0.87
Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study. PLoS One (2012) 0.87
Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. Nucleus (2013) 0.85
Estrogen receptor-beta and breast cancer: translating biology into clinical practice. Steroids (2012) 0.84
CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol (2011) 0.82
Enhancing in vivo survival of adipose-derived stromal cells through Bcl-2 overexpression using a minicircle vector. Stem Cells Transl Med (2013) 0.82
Emerin in health and disease. Semin Cell Dev Biol (2013) 0.81
Adenoviral vectors for prodrug activation-based gene therapy for cancer. Anticancer Agents Med Chem (2014) 0.81
Use of suppression subtractive hybridization to identify genes regulated by ciliary neurotrophic factor in postnatal retinal explants. Mol Vis (2007) 0.81
Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells. J Med Food (2013) 0.80
Microarray and pathway analysis reveals decreased CDC25A and increased CDC42 associated with slow growth of BCL2 overexpressing immortalized breast cell line. Cell Cycle (2008) 0.79
Null mutation of the transcription factor inhibitor of DNA binding 3 (id3) affects spermatozoal motility parameters and epididymal gene expression in mice. Biol Reprod (2010) 0.78
MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus. J Virol (2014) 0.78
DED or alive: assembly and regulation of the death effector domain complexes. Cell Death Dis (2015) 0.77
Early phosphoproteomic changes in the mouse spleen during deoxynivalenol-induced ribotoxic stress. Toxicol Sci (2013) 0.77
Dissecting the roles of tyrosines 490 and 785 of TrkA protein in the induction of downstream protein phosphorylation using chimeric receptors. J Biol Chem (2013) 0.77
Bclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence. Cell Death Differ (2016) 0.77
Proteomic Study to Survey the CIGB-552 Antitumor Effect. Biomed Res Int (2015) 0.75
Proteome dynamics during postnatal mouse corpus callosum development. Sci Rep (2017) 0.75
Identifying Causal Genes at the Multiple Sclerosis Associated Region 6q23 Using Capture Hi-C. PLoS One (2016) 0.75
Alignment of Mitotic Chromosomes in Human Cells Involves SR-Like Splicing Factors Btf and TRAP150. Int J Mol Sci (2017) 0.75
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell (1993) 20.72
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 16.53
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (1990) 14.46
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell (1993) 14.39
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (1993) 13.46
Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell (1997) 12.83
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (1996) 11.29
Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol (1997) 9.18
Programmed cell death in animal development. Cell (1997) 8.95
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
AP-1 function and regulation. Curr Opin Cell Biol (1997) 8.29
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene (1994) 7.24
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (1994) 6.69
Life, death, and the pursuit of apoptosis. Genes Dev (1996) 6.21
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev (1993) 6.02
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (1994) 4.77
Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci U S A (1996) 4.61
Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature (1997) 4.55
Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell (1995) 4.53
Mediation of c-Myc-induced apoptosis by p53. Science (1994) 4.45
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol Cell Biol (1992) 4.17
Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol (1988) 4.06
Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell (1996) 4.04
Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell (1994) 3.86
A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J (1995) 3.70
Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science (1997) 3.51
Channel formation by antiapoptotic protein Bcl-2. Proc Natl Acad Sci U S A (1997) 3.45
Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev (1995) 3.40
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol (1992) 3.37
bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development (1994) 3.34
Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (1995) 3.22
A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron (1995) 3.11
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene (1995) 2.89
Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1991) 2.86
p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol (1997) 2.84
Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol (1990) 2.76
Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol (1994) 2.75
Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol (1991) 2.71
Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol (1995) 2.62
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol (1990) 2.60
Interaction and regulation of subcellular localization of CED-4 by CED-9. Science (1997) 2.58
Ultrastructural localization of bcl-2 protein. J Histochem Cytochem (1992) 2.48
Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature (1997) 2.46
Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res (1991) 2.46
The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J (1997) 2.44
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem (1998) 2.25
The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev (1996) 2.23
Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci U S A (1996) 2.19
Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol (1994) 2.14
Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature (1997) 2.09
Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol (1994) 2.06
Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A (1998) 2.04
Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med (1996) 1.98
Bcl-2 associates with the ras-related protein R-ras p23. Nature (1993) 1.94
Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc Natl Acad Sci U S A (1989) 1.86
Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev (1996) 1.86
Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol (1998) 1.85
Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol Cell Biol (1996) 1.77
Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol (1995) 1.76
v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev (1996) 1.74
Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol (1996) 1.71
Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc Natl Acad Sci U S A (1994) 1.69
Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev (1995) 1.69
Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol Cell Biol (1995) 1.67
A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene (1993) 1.59
Myb proteins in life, death and differentiation. Curr Opin Genet Dev (1998) 1.55
Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene (1996) 1.51
A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev (1996) 1.49
Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA. Mol Cell Biol (1984) 1.46
Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy. Mech Dev (1996) 1.38
Role of the adenovirus E1B 19,000-dalton tumor antigen in regulating early gene expression. J Virol (1988) 1.36
E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J Cell Biol (1998) 1.33
Interaction and regulation of the Caenorhabditis elegans death protease CED-3 by CED-4 and CED-9. J Biol Chem (1997) 1.33
Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen. Mol Cell Biol (1986) 1.31
Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes. Genes Dev (1987) 1.30
Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene (1998) 1.26
Diminished cell proliferation associated with the death-protective activity of Bcl-2. J Biol Chem (1996) 1.23
Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J Immunol (1995) 1.19
Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res (1992) 1.13
The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K. Mol Cell Biol (1996) 0.94
Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol (1994) 0.94
Inhibition of protein synthesis prevents cell death in sensory and parasympathetic neurons deprived of neurotrophic factor in vitro. J Neurobiol (1990) 0.94
The E1B 19K protein associates with lamins in vivo and its proper localization is required for inhibition of apoptosis. Oncogene (1997) 0.91
Ultraviolet B-induced DNA fragmentation (apoptosis) in activated T-lymphocytes and Jurkat cells is augmented by inhibition of RNA and protein synthesis. Exp Hematol (1992) 0.91
E1B 19,000-molecular-weight protein interacts with and inhibits CED-4-dependent, FLICE-mediated apoptosis. Mol Cell Biol (1998) 0.91
Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes Dev (1998) 0.90
Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by Bcl-2. Mol Cell Biol (1993) 0.89
Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J Cell Biochem (1992) 0.89
Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription. Mol Cell Biol (1998) 0.88
Cytogenetic and molecular analysis of 6q deletions in Burkitt's lymphoma cell lines. Genes Chromosomes Cancer (1994) 0.87
Interleukin 1 beta converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ (1997) 0.87
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med (1999) 10.21
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev (1993) 6.02
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43
Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst (2000) 4.98
Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA (1991) 4.49
Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease. Cancer (1993) 2.70
Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol (1996) 2.55
Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst (1994) 2.51
Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst (1999) 2.49
Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst (1996) 2.49
Retaining and tracking cohort study members. Epidemiol Rev (1998) 2.45
Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst (1995) 2.36
Mycobacterium avium bacilli grow saprozoically in coculture with Acanthamoeba polyphaga and survive within cyst walls. Appl Environ Microbiol (1998) 2.36
The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev (1996) 2.23
Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol (2001) 2.23
Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J Virol (1994) 2.14
Estimating relative risk functions in case-control studies using a nonparametric logistic regression. Am J Epidemiol (1996) 2.13
Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol (1994) 2.06
Work-site smoking policies: their population impact in Washington State. Am J Public Health (1993) 2.03
Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J Virol (1984) 2.00
The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry. Br J Ophthalmol (2005) 1.88
Automatic segmentation of intra-treatment CT images for adaptive radiation therapy of the prostate. Med Image Comput Comput Assist Interv (2005) 1.83
Perinatal factors and risk of breast cancer. Epidemiology (1996) 1.82
The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene (1997) 1.79
Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol Cell Biol (1996) 1.77
Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol (1995) 1.76
Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control (1997) 1.75
Rising incidence of breast cancer among young women in Washington State. J Natl Cancer Inst (1987) 1.74
Breast cancer size and stage in Hispanic American women, by birthplace: 1992-1995. Am J Public Health (2001) 1.72
Effects of physical activity intensity, frequency, and activity type on 10-y weight change in middle-aged men and women. Int J Obes (Lond) (2005) 1.72
Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J Virol (1995) 1.70
Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev (1995) 1.69
TNF-alpha signals apoptosis through a bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol Cell (2000) 1.68
Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol (1995) 1.68
Constipation, laxative use, and colon cancer among middle-aged adults. Epidemiology (1998) 1.66
Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry (1989) 1.64
p53-dependent apoptosis pathways. Adv Cancer Res (2001) 1.58
The association between head trauma and Alzheimer's disease. Am J Epidemiol (1990) 1.58
Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics (2000) 1.55
Relationship of food groups and water intake to colon cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.54
History of lactation and breast cancer risk. Am J Epidemiol (1993) 1.52
Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol (1998) 1.52
Protection against poliomyelitis. Lancet (1977) 1.50
Ethnicity and birthplace in relation to tumor size and stage in Asian American women with breast cancer. Am J Public Health (1999) 1.48
Recent trends in breast cancer mortality among white and black US women. Am J Public Health (1997) 1.48
Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA. Mol Cell Biol (1984) 1.46
Using a brief household food inventory as an environmental indicator of individual dietary practices. Am J Public Health (1997) 1.44
Mammography diffusion and trends in late-stage breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev (1997) 1.44
Hepatitis B virus infection in dentists. N Engl J Med (1975) 1.44
Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. J Biol Chem (2001) 1.42
Validity and reliability of subject and mother reporting of perinatal factors. Am J Epidemiol (1998) 1.41
Midsummer madness: x rays and breast cancer. BMJ (1995) 1.39
The scientific study of unusual rapid wound healing: a case report. Adv Mind Body Med (2001) 1.39
Femoral artery occlusion in obese patients in the lateral position. Anaesthesia (2010) 1.38
Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control (2000) 1.36
Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins. J Virol (1987) 1.35
Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control (2001) 1.35
E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE. J Cell Biol (1998) 1.33
A comparison of four methods of tonometry: method agreement and interobserver variability. Br J Ophthalmol (2005) 1.32
Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol (1995) 1.31
Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen. Mol Cell Biol (1986) 1.31
The association between aluminum-containing products and Alzheimer's disease. J Clin Epidemiol (1990) 1.31
c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene (1995) 1.29
Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol (1994) 1.28
Both viral (adenovirus E1B) and cellular (hsp 70, p53) components interact with centrosomes. J Cell Physiol (1994) 1.27
Home collection versus publicly funded HIV testing in San Francisco: who tests where? J Acquir Immune Defic Syndr (1999) 1.26
Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis. Oncogene (1998) 1.26
Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol (1994) 1.26
E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J Virol (2001) 1.25
Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger. Cold Spring Harb Symp Quant Biol (2012) 1.25
Variation in mammographic breast density by race. Ann Epidemiol (2001) 1.24
Effect of age and breast density on screening mammograms with false-positive findings. AJR Am J Roentgenol (1999) 1.24
Tumour biology. p53, guardian of Rb. Nature (1994) 1.23
The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control (2001) 1.23
Alcohol and nutrients in relation to colon cancer in middle-aged adults. Am J Epidemiol (1993) 1.21
p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J Virol (1997) 1.21
Projected changes in breast cancer incidence due to the trend toward delayed childbearing. Am J Public Health (1987) 1.19
The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res (1993) 1.19
A case-control study to evaluate efficacy of screening for faecal occult blood. J Med Screen (1995) 1.18
Partial characterisation of Ia antigens on murine thymocytes. Nature (1975) 1.18
Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control (1994) 1.16
Melanoma risk by age and socio-economic status. Int J Cancer (1990) 1.14
Correlates of maintenance of a low-fat diet among women in the Women's Health Trial. Prev Med (1992) 1.14
Relation between obesity and breast cancer in young women. Am J Epidemiol (1999) 1.14
Do beliefs, knowledge, and perceived norms about diet and cancer predict dietary change? Am J Public Health (1996) 1.13
Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med (1990) 1.12
Changes in cytosolic calcium monitored by inward currents during action potentials in guinea-pig ventricular cells. Proc R Soc Lond B Biol Sci (1989) 1.11
Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol (1996) 1.11
Transanal endoscopic microsurgery: a viable operative alternative in selected patients with rectal lesions. Ann Surg Oncol (2003) 1.11
The role of calcium in the response of cardiac muscle to stretch. Prog Biophys Mol Biol (1999) 1.10
The accurate determination of serum glucose by isotope dilution mass spectrometry--two methods. Biomed Mass Spectrom (1982) 1.10
The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells. Oncogene (1998) 1.10
Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol (2001) 1.09
Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry (1990) 1.08
Stretch-induced increase of resting intracellular calcium concentration in single guinea-pig ventricular myocytes. Exp Physiol (1991) 1.08
Effects of enhanced calling efforts on response rates, estimates of health behavior, and costs in a telephone health survey using random-digit dialing. Public Health Rep (1993) 1.07
Allografts in genetically defined rats: difference in survival between kidney and skin. Science (1968) 1.07